To read the full paper, click here.

Susan Richman from the Leeds Institute of Cancer and Pathology obtained £1120 from the Medical Research Council (MRC)  to fund a stand  at the MRC’s Festival of Medical Research.  The stand titled, ‘So, just what is personalised Medicine?’ was split into three sections, with the first aiming to bust the stigma around bowel cancer screening, incorporating a game and a competition.

Congratulations to Margaret Grayson who received the Iris Colvin Lifetime Achievement award for Health on 21st April at Belfast City Hall. The prize was awarded by Womens Forum, Nothern Ireland who seek to facilitate and increase the involvement of women in public life in Northern Ireland. The award was given in recognition of Margarets outstanding contribution to health research as a patient advocate.

S:CORT researchers have demonstrated for the first time how molecular analysis of clinical trial biopsy samples can be used to help clinicians identify the key changes that occur in an individual patient’s bowel (colorectal) tumour prior to surgery, so clinicians can better understand and treat the disease.

European Alliance for Personalised Medicine Inaugural Congress, Belfast

“Personalising your Health – a global imperative”

27^th-30^th November 2017

Over six hundred delegates attended the inaugural event from across EU member states and held in conjunction with the Estonian presidency. S:CORT professors Tim Maughan and Richard Sullivan and Lisa Wilde from BC-UK all took part in the acclaimed session; “left behind and burnt out? The lived experience of the molecularly unstratified patient and stratified medicine researchers.” During the session both S:CORT and FOCUS4 were given as exemplars of the progress in precision medicine research. Posters were also presented during breakout sessions representing our work in the fields of; patient and public involvement, health economics and tumour heterogeneity.

The event was also attended by policy makers, patient groups and industry representatives from across Europe helping to achieve the congress objective to put personalised medicine at the forefront of European decision making on health.